Characterization and comparison of extended-spectrum β-lactamase (ESBL) resistance genotypes and population structure of Escherichia coli isolated from Franklin's gulls (Leucophaeus pipixcan) and humans in Chile

PLoS One. 2013 Sep 30;8(9):e76150. doi: 10.1371/journal.pone.0076150. eCollection 2013.

Abstract

We investigated the general level of antibiotic resistance with further analysis of extended-spectrum beta-lactamase (ESBL) prevalence, as well as the population structure of E. coli in fecal flora of humans and Franklin's gulls (Leucophaeus pipixcan) in central parts of Chile. We found a surprisingly high carriage rate of ESBL-producing E. coli among the gulls 112/372 (30.1%) as compared to the human population 6/49 (12.2%.) Several of the E. coli sequence types (STs) identified in birds have previously been reported as Multi Drug Resistant (MDR) human pathogens including the ability to produce ESBLs. This means that not only commensal flora is shared between birds and humans but also STs with pathogenic potential. Given the migratory behavior of Franklin's gulls, they and other migratory species, may be a part of ESBL dissemination in the environment and over great geographic distances. Apart from keeping the antibiotic use low, breaking the transmission chains between the environment and humans must be a priority to hinder the dissemination of resistance.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Charadriiformes / microbiology*
  • Chile
  • DNA Gyrase / genetics
  • DNA Primers / genetics
  • Demography*
  • Drug Resistance, Bacterial / genetics*
  • Escherichia coli / genetics*
  • Feces / microbiology
  • Female
  • Genotype
  • Humans
  • Male
  • Multilocus Sequence Typing
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism*

Substances

  • DNA Primers
  • beta-Lactamases
  • DNA Gyrase

Grants and funding

Anders Johansson would like to thank the Laboratory for Molecular Infection Medicine Sweden for supporting him by a Clinical Research Fellowship. This study was funded by the Swedish Research Council FORMAS (2008-326), the Karin Korsner’s and Olle Engkvist Byggmästare Foundations and the Medical Faculty, Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.